R. Campbell
Molecular Biology · with Audia · 2015–2016
A researcher in the Science corpus: 2 papers; trusts 5 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 50 citations into it; #15,770 of 17,773 by trust here, #12,008 by citations
Whom R. Campbell trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts R. Campbell overall
Papers from R. Campbell's perspective
Ordered by how strongly the researchers R. Campbell trusts endorse each paper. Same corpus, a different order for every researcher.
- Global histone modification patterns predict risk of prostate cancer recurrence (Nature)
- EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer (EMBO Journal)
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer (Nature Genetics)
- BET bromodomain inhibition as a therapeutic strategy to target c-Myc (Cell)
- Multivalent engagement of chromatin modifications by linked binding modules (Nature reviews. Molecular cell biology)
- Frequent mutation of histone modifying genes in non-Hodgkin lymphoma (Nature)
- Epigenetic antagonism between Polycomb and SWI/SNF complexes during oncogenic transformation (Cancer Cell)
- Selective inhibition of BET bromodomains (Nature)
- Targeting MYC dependence in cancer by inhibiting BET bromodomains (Proceedings of the National Academy of Sciences of the United States of America)
- Erasers of histone acetylation: the histone deacetylase enzymes. (Cold Spring Harbor Perspectives in Biology)
Their papers
- Histone Modifications and Cancer. (2016) — 859 citations
- The promise and peril of chemical probes (2015) — 739 citations